Zobrazeno 1 - 10
of 450
pro vyhledávání: '"Kyriakos P, Papadopoulos"'
Autor:
Michael Smith, Aung Naing, Todd Bauer, Kyriakos P Papadopoulos, Osama Rahma, Elena Garralda, Glenn J Hanna, Michael J Pishvaian, Xuejun Chen, Sven Gogov, Omar Saavedra, Howard Kallender, LuLu Cheng, Emil Kuriakose
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Objective The arginase inhibitor INCB001158 was evaluated for safety (primary endpoint) in locally advanced or metastatic solid tumours; pharmacokinetics, pharmacodynamics and efficacy were also assessed.Methods and analysis In this non-randomised, o
Externí odkaz:
https://doaj.org/article/2ecbc50a50ee44ec83f8a17ad29ac490
Autor:
Gady Cojocaru, Inbal Barbiro, Amita Patnaik, Manish Sharma, Drew Rasco, Benjamin Izar, Kyriakos P Papadopoulos, Eran Ophir, Ryan Sullivan, Pierre Ferre, Stéphanie Gaillard, Daniel Vaena, Oladapo Yeku, John Moroney, Adeboye H Adewoye
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a3c445d3d8fe4f368bee37e0d51c9c49
Autor:
Sapna Patel, Alain Mita, Kyriakos P Papadopoulos, Justine Cohen, Alexander Shoushtari, Jordi Rodon, Marlana Orloff, Marya Chaney, Carolyn Muller, Jessica Lin, Tina Garyantes, Monica Mita, Christopher Natale, Jeffrey Ishizuka
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/eea4b5f77786436a94e0b9b2b34ee5b4
Autor:
Omid Hamid, Siqing Fu, Manish Sharma, Anna Spreafico, Kyriakos P Papadopoulos, Erika Hamilton, Alexander Spira, Quincy Chu, Brigette Ma, Emily Roberts-Thomson, Dih-Yih Chen, Judy S Wang, Scott A Laurie, Mark R Bray, Roger Sidhu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b9d18b36b4844c1ab02ca1daf51708cf
Autor:
Igor Puzanov, Shivaani Kummar, Sylvie Rottey, Patricia LoRusso, Kyriakos P Papadopoulos, Erika Hamilton, Josef Rüschoff, Fiona C Thistlethwaite, Nuria Kotecki, Christopher T Chen, Yvan LeBruchec, Jerzy Dyczkowski, Sara Samari, Marie Toukam, Joseph Boni, Karin Havenith, Serafino Pantano
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e7bd7c5c673646de94e1c49e5f5e9618
Autor:
Gady Cojocaru, Inbal Barbiro, Manish Patel, Manish Sharma, Dale Shepard, Drew Rasco, Bartosz Chmielowski, Kyriakos P Papadopoulos, Eran Ophir, Ecaterina Dumbrava, Erika Hamilton, Pierre Ferre, Daniel Vaena, Judy S Wang, Adeboye H Adewoye
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/363ff12d124c4f2cbb2ae653c202e261
Autor:
Chia-Yu Chen, Kyriakos D. Papadopoulos
Publikováno v:
ACS Omega, Vol 5, Iss 14, Pp 7738-7744 (2020)
Externí odkaz:
https://doaj.org/article/d76d0fb6ec624cabbb959e110ed759a3
Autor:
Alyssa Simonson, Johnnie Flores, Ebony Anderson, Crystal Moreno, George Plasko, Kyriakos P. Papadopoulos, Amita Patnaik, Drew Rasco, Gladys Rodriguez, Amy Lang, Muralidhar Beeram, Luis Rodriguez, Ronald Drengler, Steven Abbate, Hanni Salih, Lon Smith, Maryam Elmi, Brittany DeBerry, Arthur Rosenthal, Tatiana Hernandez, Nehal Lakhani, Manish Sharma, Michael Wick
Publikováno v:
Cancer Research. 83:P3-08
Background: Sacituzumab govitecan (SG) is an antibody-drug conjugate targeting Trop2 with an SN-38 payload recently approved for pretreated patients with locally advanced or metastatic triple-negative breast cancer (TNBC). The XenoSTART Patient-Deriv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d808a47f1b81f2dd82b9dfcad41380da
https://doi.org/10.1158/1538-7445.sabcs22-p3-08-05
https://doi.org/10.1158/1538-7445.sabcs22-p3-08-05
Autor:
George Plasko, Johnnie Flores, Alyssa Simonson, Peter Forofontov, Ashwin Varma, Amy Lang, Gladys Rodriguez, Kyriakos P. Papadopoulos, Drew Rasco, Amita Patnaik, Bruce Conway, Joe Johnston, Michael Wick
Publikováno v:
Cancer Research. 83:P1-13
Background: Trastuzumab deruxtecan (DS-8201a) is an antibody-drug conjugate (ADC), consisting of a humanized anti-HER2 (human epidermal growth factor receptor 2) monoclonal antibody linked to a topoisomerase I inhibitor payload using a cleavable tetr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce4eb899ba6e1a24b2b052aa0d5199e9
https://doi.org/10.1158/1538-7445.sabcs22-p1-13-03
https://doi.org/10.1158/1538-7445.sabcs22-p1-13-03
Autor:
Aditya Bardia, Ian Krop, Funda Meric-Bernstam, Anthony W. Tolcher, Toru Mukohara, Aaron Lisberg, Toshio Shimizu, Erika Hamilton, Alexander I. Spira, Kyriakos P. Papadopoulos, Jonathan Greenberg, Wen Gu, Fumiaki Kobayashi, Hong Zebger-Gong, Yui Kawasaki, Rie Wong, Takahiro Kogawa
Publikováno v:
Cancer Research. 83:P6-10
Background: Datopotamab deruxtecan (Dato-DXd) is an antibody-drug conjugate (ADC) consisting of a humanized anti-TROP2 IgG1 mAb covalently linked to a highly potent topoisomerase I (Topo I) inhibitor payload via a stable, tumor selective, tetrapeptid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1880b8ce0aa7ca0ab52c94818032ace
https://doi.org/10.1158/1538-7445.sabcs22-p6-10-03
https://doi.org/10.1158/1538-7445.sabcs22-p6-10-03